Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Investment
128 Articles Available
1
6
Can't find what you're looking for? Try our
advanced search
.
Series A Financing
Syncona founds Quell Therapeutics with £35 million Series A Financing
PR-M05-19-NI-063
Financing
Schrödinger Announces Close of Latest Financing, Raising a Total of $110 Million
PR-M05-19-NI-062
Funding
Philogen Raises $70 Million
PAO-M05-19-NI-019
Financing
Actuate Therapeutics Completes $21.7 Million Series B Financing
PR-M05-19-NI-061
Financing
KNOW Bio Announces Closing of $30 Million in Equity Financing
PR-M05-19-NI-048
Investment
Fengate Exceeds Fundraising Target and Closes Core Infrastructure Fund III with $1.1 Billion in Capital Commitments
PR-M05-19-NI-046
Investment
LeapFrog Breaks Impact Investing Record, with $700M Emerging Markets Fund
PR-M05-19-NI-043
Investment
Bayer Invests $150 Million to Build New Cell Culture Technology Center in Berkeley to Spur Innovation of Biotech Therapies
PR-M05-19-NI-040
Funding
Elligo Health Research Raises $20M to Connect More Physicians and Their Patients to Clinical Research as a Care Option
PR-M05-19-NI-033
Financing
KIYATEC Announces $3 Million Initial Closing of Series B2 Preferred Stock Financing and New Investor LabCorp
PR-M05-19-NI-031
Earnings
Invitae Reports 47% Growth in Quarterly Revenue and Volume Year-Over-Year
PR-M05-19-NI-026
Earnings
Insulet Reports First Quarter 2019 Revenue of $159.6 Million, an Increase of 29% Year-Over-Year
PR-M05-19-NI-021
Investment
Novus Therapeutics Announces Closing of $10.7 Million Registered Direct Offering Priced At-the-Market
PR-M05-19-NI-019
Financial Results
Gilead Sciences Announces First Quarter 2019 Financial Results
PR-M05-19-NI-018
Finance
Perrigo Increases Its Dividend By 11%
PR-M04-19-NI-090
Series C Financing
Sirnaomics Closes $47 Million Series C Financing to Develop RNAi Therapeutics for Treatment of Cancer and Fibrotic Diseases
PR-M04-19-NI-091
Finance
Pharma Company Tax Savings Went to Investors and Stock Buybacks
PAO-M04-19-NI-017
Capacity Expansion
Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000 L
PR-M04-19-NI-057
Form-Fill-Seal
Investing in Form-Fill-Seal Technology
PAP-Q1-2019-CL-011
Series B Financing
ABK Biomedical Raises $30M in Series B Financing
PR-M04-19-NI-039
Drug Development
New $22 Million Project Targets Deadly Viruses
PR-M04-19-NI-033
Investment
Citius Announces $5.3 Million Registered Direct Offering Priced At-the-Market
PR-M04-19-NI-024
Funding
BillionToOne Announces $15 Million Series A, Co-Led by Hummingbird and NeoTribe
PR-M04-19-NI-005
Business
Alcon Going on Its Own
PAO-M03-19-NI-038
1
6
»
